TMI versus NEG | TMI versus ILA | ILA versus NEG | ||||||
Gene | FC | BY P value | Gene | FC | BY P value | Gene | FC | MW p value* |
CXCL9 | 71.4 | 0.000001 | CCL18 | 19.0 | 0.000019 | CXCL9 | 3.9 | 0.011072 |
CCL18 | 58.9 | 0.000001 | CXCL9 | 18.1 | 0.000063 | CD163 | 3.8 | 0.011072 |
SPP1 | 43.1 | 0.000036 | CHIT1 | 14.9 | 0.000146 | IL7R | 3.7 | 0.037879 |
CHIT1 | 31.4 | 0.000011 | SPP1 | 12.7 | 0.002058 | GZMK | 3.7 | 0.026224 |
MARCO | 18.4 | 0.000011 | MARCO | 11.6 | 0.000047 | GZMA | 3.6 | 0.004079 |
ITGB2 | 16.5 | 0.000001 | CCL19 | 10.7 | 0.000012 | IL2RG | 3.3 | 0.006993 |
C1QB | 15.7 | 0.000001 | CYBB | 7.7 | 0.000019 | CR1 | 3.2 | 0.011072 |
LTB | 15.5 | 0.000001 | IDO1 | 7.4 | 0.000012 | CCL18 | 3.1 | 0.026224 |
ITGAX | 15.3 | 0.000001 | CD74 | 7.4 | 0.000012 | CD53 | 3.1 | 0.026224 |
CYBB | 15.0 | 0.000001 | IL2RB | 7.3 | 0.000012 | FCGR3A | 2.9 | 0.011072 |
MCAM | −9.8 | 0.000001 | MCAM | −6.9 | 0.000146 | |||
RRAD | −7.5 | 0.000050 | RRAD | −5.2 | 0.000374 | |||
TGFB2 | −5.1 | 0.000003 | MFGE8 | −4.9 | 0.000012 | |||
MFGE8 | −4.9 | 0.000001 | CX3CL1 | −4.5 | 0.000063 | |||
CYFIP2 | −4.3 | 0.000001 | CYFIP2 | −3.9 | 0.000146 | |||
CX3CL1 | −4.2 | 0.000018 | PDGFRB | −3.3 | 0.000842 | |||
CFD | −4.1 | 0.000790 | TGFB2 | −3.3 | 0.001453 | |||
PPBP | −3.8 | 0.020432 | LRRN3 | −3.3 | 0.000146 | |||
JAM3 | −3.7 | 0.000001 | JAM3 | −3.2 | 0.000012 | |||
IGF1R | −3.7 | 0.000001 | CCL14 | −3.1 | 0.004051 |
*Uncorrected p values resulting from Mann-Whitney test.
BY, Benjamini-Yekutieli ; FC, fold changes; ILA, inflammation limited to adventitia; NEG, normal temporal artery biopsies without inflammation from patients without GCA; TABs, temporal artery biopsies; TMI, transmural inflammation.